Loading clinical trials...
Loading clinical trials...
Phase 1 Open-Label, Dose-Escalation Study of the Safety, Tolerability and Preliminary Efficacy of Intravitreal 4D-110 in Patients With Choroideremia
Conditions
Interventions
4D-110
Locations
2
United States
Retina Foundation of the Southwest
Dallas, Texas, United States
Moran Eye Center, University of Utah
Salt Lake City, Utah, United States
Start Date
June 2, 2020
Primary Completion Date
May 26, 2027
Completion Date
August 31, 2027
Last Updated
May 22, 2025
NCT02407678
NCT02670980
NCT01603576
Lead Sponsor
4D Molecular Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions